Nifty Pharma Today: Index Gains 0.85% to Close at 26,564

Closing Bell, 25 August 2026:Nifty Pharma finished as the top gaining sector index among the configured sector indices, rising 224.70 points, or 0.85%, to 26,564. The index closed close to its intraday high of 26,574 after trading between 26,214.90 and 26,574.

Quick sector takeaways

• Nifty Pharma today rose 0.85% to 26,564 from a previous close of 26,339.30.
• The index advanced 224.70 points and ended only 10 points below its session high of 26,574.
• Breadth was constructive: 12 of 20 displayed stocks advanced, while eight declined.
• Laurus Labs, Divi’s Laboratories, Biocon and Zydus Lifesciences led the gainers; traders can watch whether participation remains broad next session.

Nifty Pharma today: a firm closing-bell performance

Nifty Pharma today delivered the strongest percentage gain among the configured sector indices. The index opened at 26,340.20, almost in line with its previous close of 26,339.30, then moved through a 359.10-point intraday range before ending at 26,564. That close represented a positive finish for the sector and placed the index near the day’s high.

The move was not confined to a single visible stock. Twelve of the 20 displayed pharmaceutical shares ended higher, giving the advance a favourable breadth profile. At the same time, eight stocks declined, showing that the sector’s rise contained stock-specific divergence rather than uniform gains across every name.

Price snapshot

The closing level was 10 points below the high, an observation that underlines the index’s late-session position within its day range. The day low was 124.40 points below the previous close, while the close finished 349.10 points above that low. These are session-price observations, not forecasts for the next move.

Sector ranking

Nifty Pharma was the top gaining sector index in the configured universe on 25 August. Its 0.85% gain was ahead of Nifty Mid Select at 0.69%, Nifty IT at 0.57%, Nifty Auto at 0.40%, Nifty FMCG at 0.38% and Nifty Financial Services at 0.34%. This ranking makes pharma the day’s leading sector-index performer within the tracked group.

The leadership was measured by the actual closing percentage change in the sector index. Nifty Bank and Nifty Metal finished marginally lower, while the remaining configured indices posted smaller gains. For readers tracking sector rotation, the ranking gives a clear end-of-session view of where the strongest index-level move occurred.

Constituent breadth

The sector’s displayed breadth favoured gainers, with 12 advancers and eight decliners among 20 stocks. There were no unchanged stocks. The advance-decline ratio was 1.5, meaning the number of stocks rising was one-and-a-half times the number falling.

This breadth supports the positive index close, while the eight decliners remain important context. A positive sector index can coexist with meaningful dispersion among constituent shares, as was visible in the contrast between the leading gainers and the day’s sharper losers.

Heavyweights versus broader participation

Among the supplied heavyweight stocks, Divi’s Laboratories rose 2.92% to ₹8,744.50 and closed at its day high. Sun Pharmaceutical Industries gained 0.63% to ₹1,922, also at its day high, while Torrent Pharmaceuticals added 0.93% to ₹4,932, its session high.

Dr. Reddy’s Laboratories increased 0.29% to ₹1,193.50 and also ended at its high. Cipla moved the other way, falling 1.11% to ₹1,422. The mix shows that gains in several supplied heavyweight names accompanied the broader positive breadth, although heavyweight performance was not unanimous.

Key Nifty Pharma stocks

Biggest positive movers

Laurus Labs led the gainers with a 3.62% rise to ₹1,866.20, ending ₹3.20 below its day high of ₹1,869.40. Divi’s Laboratories added 2.92% to ₹8,744.50, matching its intraday high. Biocon rose 1.91% to ₹417.20 and also finished at the day high.

Zydus Lifesciences gained 1.88% to ₹1,124.50, just below its ₹1,125 high. Torrent Pharmaceuticals completed the leading group with a 0.93% rise to ₹4,932, its day high. These moves provided the strongest positive stock-level readings in the displayed basket.

Biggest negative movers

JB Chemicals & Pharmaceuticals declined 3.87% to ₹2,408.90, the largest fall among the displayed names. Natco Pharma fell 2.01% to ₹866.25, ending close to its day low of ₹865. Cipla lost 1.11%, Granules India slipped 1.09%, and Ajanta Pharma fell 0.70%.

These declines are a reminder that the sector’s 0.85% index gain was accompanied by differentiated stock moves. Monitoring whether these lagging shares remain under pressure or participate in a broader recovery can add context to the next session’s breadth.

Stocks to watch next session

• Laurus Labs: after a 3.62% rise to ₹1,866.20, against a day high of ₹1,869.40.
• Divi’s Laboratories: after closing at its day high of ₹8,744.50.
• Biocon: after ending at its day high of ₹417.20.
• Zydus Lifesciences: after closing at ₹1,124.50 against a ₹1,125 high.
• JB Chemicals & Pharmaceuticals: after a 3.87% decline to ₹2,408.90.
• Natco Pharma: after ending at ₹866.25, near its ₹865 day low.

The constructive case

The constructive evidence is visible in the closing data: Nifty Pharma gained 0.85%, ranked first among the configured sector indices, and finished just below its intraday high. The index also closed above both its opening level and previous close.

Stock participation adds to that picture. Twelve displayed shares advanced, and notable gains came from Laurus Labs, Divi’s Laboratories, Biocon, Zydus Lifesciences and Torrent Pharmaceuticals. Several supplied heavyweight names also finished higher, with Divi’s Laboratories, Sun Pharmaceutical Industries, Torrent Pharmaceuticals and Dr. Reddy’s Laboratories at their respective day highs.

The cautious case

The sector advance was constructive but not universal. Eight of the 20 displayed stocks declined, led by JB Chemicals & Pharmaceuticals and Natco Pharma. Cipla, Granules India, Ajanta Pharma, Lupin, Mankind Pharma and Abbott India also ended lower.

The next session’s reading will therefore depend on whether the positive breadth expands beyond 12 advancers and whether the stocks that declined can stabilise alongside the index. The intraday range from 26,214.90 to 26,574 also shows that the sector saw two-way movement before its firm close.

Univest Insights

At the closing bell, pharma stood out on relative sector-index performance. The 224.70-point advance lifted the index to 26,564 from 26,339.30, with the close holding near the session peak. For an updated overview of the broader market, visit Univest Market View.

The makeup of the advance matters as much as the headline percentage move. Laurus Labs was the strongest displayed gainer, while Divi’s Laboratories combined a substantial 2.92% rise with a close at the day high. Positive moves in Sun Pharmaceutical Industries and Torrent Pharmaceuticals added favourable context among the supplied heavyweight stocks.

However, the presence of eight decliners means the sector did not move in a single direction at the stock level. The contrast between gains in Divi’s Laboratories and Laurus Labs and declines in JB Chemicals & Pharmaceuticals and Natco Pharma makes breadth a practical follow-through measure.

Nifty Pharma today closed as the leading configured sector index, with its near-high finish and 12-8 positive breadth split forming the central closing-bell signal. For traders and investors, the key signal to watch is…

Published on 25 August 2026 at 4:15 PM IST

Frequently asked questions

What was Nifty Pharma today?

Nifty Pharma closed at 26,564 on 25 August 2026, up 224.70 points or 0.85% from 26,339.30.

What were Nifty Pharma’s intraday high and low?

The index traded between a day low of 26,214.90 and a day high of 26,574.

Why was Nifty Pharma the top gaining sector index?

Its 0.85% rise was the highest percentage gain among the configured sector indices for the session.

How was the breadth in Nifty Pharma stocks?

Among 20 displayed stocks, 12 advanced and eight declined, with no unchanged stocks.

Which stocks were the top gainers in Nifty Pharma?

Laurus Labs, Divi’s Laboratories, Biocon, Zydus Lifesciences and Torrent Pharmaceuticals were the leading displayed gainers.

Which stocks declined the most in Nifty Pharma?

JB Chemicals & Pharmaceuticals, Natco Pharma, Cipla, Granules India and Ajanta Pharma were the leading displayed decliners.